DARE BIOSCIENCE INC's ticker is DARE and the CUSIP is 23666P101. A total of 38 filers reported holding DARE BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,662 | -49.3% | 62,065 | 0.0% | 0.14% | -39.6% |
| Q2 2023 | $56,485 | -12.5% | 62,065 | 0.0% | 0.23% | -25.8% |
| Q1 2023 | $64,548 | +25.3% | 62,065 | 0.0% | 0.31% | +25.0% |
| Q4 2022 | $51,514 | -16.9% | 62,065 | 0.0% | 0.25% | +29.8% |
| Q3 2022 | $62,000 | -18.4% | 62,065 | 0.0% | 0.19% | +35.5% |
| Q2 2022 | $76,000 | -17.4% | 62,065 | 0.0% | 0.14% | +302.9% |
| Q1 2022 | $92,000 | -25.8% | 62,065 | 0.0% | 0.04% | -52.1% |
| Q4 2021 | $124,000 | +19.2% | 62,065 | 0.0% | 0.07% | +69.8% |
| Q3 2021 | $104,000 | +9.5% | 62,065 | +23.2% | 0.04% | +43.3% |
| Q2 2021 | $95,000 | +11.8% | 50,368 | 0.0% | 0.03% | +36.4% |
| Q1 2021 | $85,000 | +26.9% | 50,368 | 0.0% | 0.02% | +175.0% |
| Q4 2020 | $67,000 | +34.0% | 50,368 | 0.0% | 0.01% | -42.9% |
| Q3 2020 | $50,000 | 0.0% | 50,368 | 0.0% | 0.01% | -65.9% |
| Q2 2020 | $50,000 | +16.3% | 50,368 | 0.0% | 0.04% | -8.9% |
| Q1 2020 | $43,000 | +4.9% | 50,368 | 0.0% | 0.04% | +150.0% |
| Q4 2019 | $41,000 | – | 50,368 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 62,065 | $64,548 | 0.31% |
| Soviero Asset Management, LP | 130,000 | $135,200 | 0.07% |
| IFS Advisors, LLC | 11,400 | $11,856 | 0.05% |
| FOUNDERS FINANCIAL SECURITIES LLC | 114,000 | $118,560 | 0.02% |
| Virtu Financial LLC | 32,481 | $34 | 0.00% |
| Renaissance Technologies | 569,059 | $592 | 0.00% |
| Tower Research Capital LLC (TRC) | 16,885 | $17 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 4,400 | $4,576 | 0.00% |
| WELLS FARGO & COMPANY/MN | 587 | $610 | 0.00% |
| NORTHERN TRUST CORP | 161,668 | $168,135 | 0.00% |